Callahan P M, Bryan S K, Cunningham K A
University of Texas Medical Branch, Department of Pharmacology and Toxicology J-31, Galveston 77555-1031, USA.
Pharmacol Biochem Behav. 1995 Aug;51(4):759-66. doi: 10.1016/0091-3057(95)00027-t.
Mesolimbic dopamine (DA) D1 and D2 receptors appear to be involved in mediating the discriminative stimulus effects of cocaine. The purpose of the present study was to investigate the role of the amygdala DA D1 receptors, in modulating the stimulus effects of cocaine. Thus, rats were trained to discriminate cocaine (10 mg/kg, IP) from saline using a two-lever, water-reinforced FR 20 drug discrimination task. In substitution tests, systemic (IP) administration of cocaine (0.625-20 mg/kg) produced a dose-related increase in cocaine-lever responding. Intracranial bilateral injections of cocaine (20-200 micrograms, total dose) into the central amygdala engendered, at best, a partial substitution (< 60% drug-lever responding) for the systemic cocaine cue. Central amygdala microinjections of artificial cerebrospinal fluid (ACSF; 1 microliter/side) or SCH 23390 (0.5-2 microgram, total dose) resulted in primarily saline-appropriate responding. In antagonism tests, bilateral injections of the DA D1 receptor antagonist SCH 23390 (0.5-2 microgram, total dose) into the central amygdala produced a dose-related blockade of a systemic dose of cocaine (5 mg/kg) that engendered > 85% cocaine-lever responding when given alone. Additionally, bilateral injection of a fixed dose of SCH 23390 (2 micrograms) into the central amygdala resulted in a rightward shift in the cocaine dose-response curve (2.5-20 mg/kg). Although administration of cocaine into the central amygdala does not mimic the systemic cocaine cue, the present results demonstrate that DA D1 receptors located within the central amygdala appear to have a modulatory role upon the discriminative stimulus properties of cocaine.
中脑边缘多巴胺(DA)D1和D2受体似乎参与介导可卡因的辨别性刺激效应。本研究的目的是调查杏仁核DA D1受体在调节可卡因刺激效应中的作用。因此,使用双杠杆、水强化FR 20药物辨别任务训练大鼠区分可卡因(10毫克/千克,腹腔注射)和生理盐水。在替代试验中,腹腔注射可卡因(0.625 - 20毫克/千克)会使可卡因杠杆反应呈剂量相关增加。向中央杏仁核双侧颅内注射可卡因(20 - 200微克,总剂量)最多只能产生部分替代(<60%药物杠杆反应)以替代全身可卡因线索。向中央杏仁核微量注射人工脑脊液(ACSF;1微升/侧)或SCH 23390(0.5 - 2微克,总剂量)主要导致适合生理盐水的反应。在拮抗试验中,向中央杏仁核双侧注射DA D1受体拮抗剂SCH 23390(0.5 - 2微克,总剂量)会对全身剂量的可卡因(5毫克/千克)产生剂量相关的阻断作用,单独给予该剂量可卡因时会产生>85%的可卡因杠杆反应。此外,向中央杏仁核双侧注射固定剂量的SCH 23390(2微克)会使可卡因剂量 - 反应曲线(2.5 - 20毫克/千克)向右移动。虽然向中央杏仁核注射可卡因不能模拟全身可卡因线索,但目前的结果表明,位于中央杏仁核的DA D1受体似乎对可卡因的辨别性刺激特性具有调节作用。